Gabapentin Capsule
Product Images NDC 71610-072

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 71610-072). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label 100 mg (71610 0072 60)

This is a prescription drug called Gabapentin available in the form of 90 capsules with each capsule containing 100mg of the medicine. The NOC# is 71610007260.*

FDA Label Image

Aphena Pharma Solutions (TN)

FDA Label Image

1 (Image 1)

The given text appears to be a medical formula for calculating creatinine clearance (cLcr) in patients. It involves taking into account the patient's age, weight, and serum creatinine level. However, without additional context or explanation, it may be difficult to interpret or use this formula accurately.*

FDA Label Image

1 (Image 10)

FDA Label Image

1 (Image 11)

FDA Label Image

1 (Image 12)

FDA Label Image

1 (Image 2)

FDA Label Image

1 (Image 3)

FDA Label Image

1 (Image 4)

FDA Label Image

1 (Image 5)

FDA Label Image

1 (Image 6)

This appears to be a table or graph with a column labeled "Mean Pain Score" and a row with different treatments (O-Placebo and Gabapentin, 3600 mg/day) and a dose titration period followed by a fixed dose period. The score for Gabapentin, 3600 mg/day is not visible. The table also includes a baseline and a timeframe of weeks. Without the complete context and additional information, it is difficult to provide a more specific description or interpretation.*

FDA Label Image

2 (Image 7)

This passage appears to be displaying data related to pain scores and gabapentin dosage during a fixed four week period. The mean pain score is listed as 0 and there is a graph depicting the neck dose titration period and the fixed dose period of four weeks. Two dosages of gabapentin (1800 mg/day and 2400 mg/day) are being compared. There is also a label indicating the number of weeks, but no further information is provided.*

FDA Label Image

3 (Image 8)

FDA Label Image

4 (Image 9)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.